[BGLC] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
14-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 68.57%
YoY- 75.28%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 7 3,070 53 24 22 28 9 -15.43%
PBT -66 -47 -96 -50 -69 -60 -63 3.15%
Tax 0 1 -4 -28 1 1 0 -
NP -67 1,070 -93 -22 -70 -61 -63 4.19%
Tax Rate - - - - - - - -
Total Cost 73 2,000 146 46 92 90 72 0.92%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -1,017.23 34.84 -174.51 -91.13 -325.24 -218.84 -669.43 32.20%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.01 0.12 -0.01 -0.00 -0.01 -0.01 -0.01 0.00%
EPS Diluted -0.01 0.12 -0.01 -0.00 -0.01 -0.01 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.